产品说明书

Xylometazoline HCl

Print
Chemical Structure| 1218-35-5 同义名 : Xylometazoline (hydrochloride);Xylometazoline hydrochloride
CAS号 : 1218-35-5
货号 : A124255
分子式 : C16H25ClN2
纯度 : 97%
分子量 : 280.836
MDL号 : MFCD00238707
存储条件:

粉末 Inert atmosphere,Room Temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 25 mg/mL(89.02 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 50 mg/mL(178.04 mM),配合低频超声助溶

动物实验配方:

PO 0.5% CMC-Na 50 mg/mL suspension

生物活性
描述 Xylometazoline hydrochloride is used as nasal mucosa decongesting α-adrenoceptor agonists during a common cold[2]. Xylometazoline is an effective and well-tolerated decongestant nasal spray that significantly relieved nasal congestion compared with placebo in the common cold and provided long-lasting relief with just 1 spray, helping patients to breathe more easily for a longer period of time[3]. Using the decongestant efficacy provided by xylometazoline HCl(Hydrochloride) and the effectiveness to reduce viral infection accomplished by iota-carrageenan can combine into a new product[4].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01971762 - Completed - Spain ... 展开 >> Hospital de Puerto Real Puerto Real, Cádiz, Spain Hospital Costa del Sol Marbella, Málaga, Spain Hospital de Torrecárdenas Almería, Spain Hospital de barcelona - SCIAS Barcelona, Spain Hospital de Cruces Bilbao, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Reina Sofía Córdoba, Spain Hospital Virgen de las Nieves Granada, Spain Hospital Juan Ramón Jiménez Huelva, Spain Hospital de San Pedro Logroño, Spain Hospital de la Arrixaca Murcia, Spain Hospital Carlos Haya Málaga, Spain Hospital Virgen de la Victoria Málaga, Spain Hospital de Valdecillas Santander, Spain Hospital Universitario Virgen de la Macarena Sevilla, Spain Hospital Virgen de Valme Sevilla, Spain 收起 <<
NCT03323684 Laparoscopic Cholecystectomy Not Applicable Completed - Egypt ... 展开 >> Mansoura University, Faculty of Medicine Mansourah, DK, Egypt, 050 Mansoura University Mansourah, DK, Egypt, 050 收起 <<
NCT01819597 Intracranial Arterial Stenosis... 展开 >> Intracranial Atherosclerosis Ischemic Stroke Cerebral Angiogenesis 收起 << Phase 2 Recruiting June 2018 United States, California ... 展开 >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Nestor R Gonzalez, MD, FAHA    310-423-0783    nestor.gonzalez@cshs.org    Contact: Antoinette Anderson    310-423-0783    antoinette.anderson@cshs.org    Principal Investigator: Nestor R Gonzalez, MD          Sub-Investigator: Jeffrey Saver, MD          Sub-Investigator: Patrick Lyden, MD          Sub-Investigator: Konrad Schlick, MD          Sub-Investigator: Shlee Song, MD          Sub-Investigator: Michael Alexander, MD          Sub-Investigator: Wouter Schievink, MD          Sub-Investigator: Oana Dumitrascu, MD 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.56mL

0.71mL

0.36mL

17.80mL

3.56mL

1.78mL

35.61mL

7.12mL

3.56mL

参考文献

[1]Haenisch B, Walstab J, et al. Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010 Dec;24(6):729-39.

[2]Haenisch B, Walstab J, Herberhold S, Bootz F, Tschaikin M, Ramseger R, Bönisch H. Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010 Dec;24(6):729-39. doi: 10.1111/j.1472-8206.2009.00805.x. PMID: 20030735.

[3]Eccles R, Eriksson M, Garreffa S, Chen SC. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol. 2008 Sep-Oct;22(5):491-6. doi: 10.2500/ajr.2008.22.3202. Epub 2008 Jul 24. PMID: 18655753.

[4]Graf C, Bernkop-Schnürch A, Egyed A, Koller C, Prieschl-Grassauer E, Morokutti-Kurz M. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis. Int J Gen Med. 2018 Jul 4;11:275-283. doi: 10.2147/IJGM.S167123. PMID: 30013382; PMCID: PMC6037157.